Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.
A tremendous opportunity for individuals with lupus to contribute to lupus drug development by sharing how the disease affects their daily lives.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.
The year-long initiative to make research on lupus treatments more inclusive and effective formally began on July 1.
The provision was approved by the U.S. House of Representatives' Appropriations Committee.
Lupus organizations announce groundbreaking collaborative initiative to inform lupus drug development.
A new study suggests that testing positive for lupus anticoagulant antibodies in the first trimester of pregnancy is the strongest predictor of pregnancy loss in women with lupus.